ALLIANCEBERNSTEIN L.P. - THERAVANCE INC ownership

THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 152 filers reported holding THERAVANCE INC in Q2 2013. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of THERAVANCE INC
ValueSharesWeighting
Q4 2015$1,541,000
+46.8%
146,1870.0%0.00%0.0%
Q3 2015$1,050,000
-80.8%
146,187
-51.6%
0.00%
-80.0%
Q2 2015$5,462,000
+3.1%
302,245
-10.3%
0.01%
+25.0%
Q1 2015$5,300,000
+45.7%
337,125
+31.1%
0.00%
+33.3%
Q4 2014$3,638,000
-91.9%
257,083
-90.2%
0.00%
-92.1%
Q3 2014$44,910,000
-47.9%
2,627,862
-9.3%
0.04%
-47.9%
Q2 2014$86,240,000
+17.2%
2,895,897
+21.7%
0.07%
+14.1%
Q1 2014$73,599,000
+1290.0%
2,378,752
+1501.5%
0.06%
+1180.0%
Q4 2013$5,295,000
-1.3%
148,534
+13.2%
0.01%0.0%
Q3 2013$5,366,000
+2.3%
131,219
-3.6%
0.01%
-16.7%
Q2 2013$5,245,000136,1230.01%
Other shareholders
THERAVANCE INC shareholders Q2 2013
NameSharesValueWeighting ↓
Baupost Group 20,395,056$607,365,0009.89%
Realm Partners LLC 301,521$8,979,0003.75%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 2,805,837$83,558,0002.52%
IRIDIAN ASSET MANAGEMENT LLC/CT 7,447,743$221,794,0002.27%
SECTORAL ASSET MANAGEMENT INC 1,743,188$51,912,0002.20%
Foundation Asset Management, LP 255,790$7,617,0002.19%
Proxima Capital Management, LLC 550,000$16,379,0001.93%
Roundview Capital LLC 140,645$4,188,0001.69%
BB BIOTECH AG 933,244$27,792,0001.32%
PERRY CAPITAL 1,517,208$45,182,0001.25%
View complete list of THERAVANCE INC shareholders